# Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer.

**Organizacion:** ESMO
**Autores:** Park KH, Loibl S, Sohn J
**Revista:** ESMO Open (2024)
**PMID:** 38796284 | **PMCID:** PMC11145753
**DOI:** [10.1016/j.esmoop.2024.102974](https://doi.org/10.1016/j.esmoop.2024.102974)
**Fuente:** PubMed Central (open access)

## Relevancia
Guia de practica clinica oficial de la European Society for Medical Oncology para diagnostico, tratamiento y seguimiento de cancer de mama temprano. Establece estandares europeos sobre estadiaje axilar, indicacion de BSGC tras NAC y manejo de la respuesta axilar patologica.

## Recomendaciones clave (resumen)
- Para cN+ -> ypN0 despues de NAC, BSGC es opcion si se utilizan tecnicas de baja tasa de falsos negativos (TAD, >=3 ganglios extraidos, doble trazador).
- ALND completa sigue siendo estandar si hay enfermedad residual ganglionar (ypN+) o si las tecnicas de mapeo no son optimas.
- Recomienda colocacion de clip/marcador en el ganglio positivo al diagnostico para localizacion post-NAC.
- Define el papel de la radioterapia regional en funcion del estado ganglionar post-NAC.

## Abstract
The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer were updated and published online in 2023, and adapted to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with early breast cancer. The adapted guidelines represent the consensus opinions reached by a panel of Asian experts representing the oncological societies of China, Indonesia, India, Japan, Korea, Malaysia, the Philippines, Singapore, Taiwan and Thailand, co-ordinated by ESMO and KSMO.

## Acceso
Disponible en PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC11145753/

---
*Datos de PubMed. Citar: doi 10.1016/j.esmoop.2024.102974*
